Baggi, F., Andreetta, F., Caspani, E., Milani, M., Longhi, R., Mantegazza, R., . . . Antozzi, C. (1999). Oral administration of an immunodominant T-cell epitope downregulates Th1/Th2 cytokines and prevents experimental myasthenia gravis. American Society for Clinical Investigation.

Baggi, Fulvio, Francesca Andreetta, Elisabetta Caspani, Monica Milani, Renato Longhi, Renato Mantegazza, Ferdinando Cornelio, und Carlo Antozzi. Oral Administration of an Immunodominant T-cell Epitope Downregulates Th1/Th2 Cytokines and Prevents Experimental Myasthenia Gravis. American Society for Clinical Investigation, 1999.

Baggi, Fulvio, et al. Oral Administration of an Immunodominant T-cell Epitope Downregulates Th1/Th2 Cytokines and Prevents Experimental Myasthenia Gravis. American Society for Clinical Investigation, 1999.